Skip to content
Advertisement
Menu
Explore journals
Get published
About BMC
Search
Login
My Account
Search all BMC articles
Search
Critical Care
Menu
Home
About
Articles
Submission Guidelines
Table of Contents
Table of contents
P001 Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux
P002 Lower serum immunoglobulin G2 level does not predispose to severe flu
P003 Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsis
P004 Adenosine a1 receptor dysfunction is associated with leukopenia: A possible mechanism for sepsis-induced leukopenia
P005 Analysis of neutrophil by hyper spectral imaging - A preliminary report
P006 Chemiluminescent intensity assessed by eaa predicts the incidence of postoperative infectious complications following gastrointestinal surgery
P007 Serial change of c1 inhibitor in patients with sepsis – A prospective observational study
P008 Comparison of bacteremia and sepsis on sepsis related biomarkers
P009 The changes of procalcitonin levels in critical patients with abdominal septic shock during blood purification
P010 Validation of a new sensitive point of care device for rapid measurement of procalcitonin
P011 Infection biomarkers in primary care patients with acute respiratory tract infections – Comparison of procalcitonin and C-reactive protein
P012 Do we need a lower procalcitonin cut off?
P013 The predictive role of C-reactive protein and procalcitonin biomarkers in central nervous system infections with extensively drug resistant bacteria
P014 Changes in endotoxin activity assay and procalcitonin levels after direct hemoperfusion with polymyxin-b immobilized fiber
P015 Diagnostic usefullness of combination biomarkers on ICU admission
P016 Platelet function analysis utilising the PFA-100 does not predict infection, bacteraemia, sepsis or outcome in critically ill patients
P017 Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients
P018 Il-8: is this a more reliable biomarker for sepsis severity than CRP, Procalcitonin, E-selectin, IL-6 and TNF-[alpha]
P019 Relation between adrenomedullin and short-term outcome in ICU patients: Results from the frog ICU study
P020 Impact of disease severity assessment on performance of heparin-binding protein for the prediction of septic shock
P021 Kinetics and prognostic value of presepsin (sCD14) in septic patients. A pilot study
P022 Comparison of CD64 levels performed by the facs and accellix systems
P023 Diagnosing sepsis in 5 minutes: Nanofluidic technology study with pancreatic-stone protein (PSP/ reg)
P024 How nanotechnology-based approaches could contribute to sepsis prevention, diagnosis and treatment
P025 Il7r transcriptional expression analysis during septic shock
P026 Disbalance of microbial metabolites of aromatic acids affects the severity in critically ill patients
P027 Copeptin predicts 10-year all-cause mortality in community patients
P028 Identification of differential proteomic response in septic patients secondary to community and hospital acquired pneumonia
P029 Monocyte HLA-DR expression in community-acquired bacteremic sepsis - dynamics associated to aetiology and prediction of secondary sepsis
P030 Soluble B- and T-lymphocyte attenuator: A possible prognostic marker in sepsis
P031 Fractal dimension: A new biomarker for quantifying clot microstructure in patients across the sepsis spectrum
P032 Comparison between the new biomarker for coagulation, clot microstructure (Df) with rotational thromboelastometry (ROTEM) in patients across the sepsis spectrum
P033 Changes in fibrinolysis across the sepsis spectrum: The use of rotational thromboelastometry (ROTEM) lysis index (LI60) and D-Dimer concentration
P034 The intensive care infection score – a promising marker for the prediction of infection and its severity
P035 Challenges in the clinical diagnosis of sepsis
P036 Does zero heat flux thermometry more accurately identify sepsis on intensive care?
P037 Advancing quality (AQ) sepsis programme: Improving early identification & treatment of sepsis in North West England.
P038 Prehospital transport of acute septic patients
P039 Vasodilatory plant extracts gel as an alternative treatment for fever in critically ill patients
P040 Host response and outcome of hypothermic sepsis
P041 Septic shock alert over SIRS criteria has an impact on outcome but needs to be revised
P042 Association between previous prescription of βblockers and mortality rate among septic patients: A retrospective observational study
P043 Recognition and treatment of sepsis on labour ward– teaching & information resources can improve knowledge
P044 Culture negative sepsis in the ICU – what is unique to this patient population?
P045 Organ dysfunction in severe sepsis patients identified in administrative data in Germany, 2007-2013
P046 A comparison of residents’ knowledge regarding; the Surviving Sepsis Campaign 2012 guideline
P047 Effectiveness of a septic shock bundle to improve outcomes in the ICU
P048 Dose of norepinephrine in the first 24 hours as a parameter evaluating the effectiveness of treatment in patients with severe sepsis and septic shock
P049 Norepinephrine or vasopressin + norepinephrine in septic shock. A retrospective series of 39 patients
P050 Methylene blue effectiveness as contributory treatment in patients with septic shock
P051 Coagulation disorders in patients with severe sepsis and DIC evaluated with thromboelastometry
P052 Frequency and outcome of early sepsis-associated coagulopathy
P053 Assessment of coagulopathy in cancer patients with severe sepsis or septic shock. A case-control pilot study
P054 Thromboelastometry in critically ill patients with disseminated intravascular coagulation
P055 Cessation of a preexisting chronic antiplatelet therapy is associated with increased mortality rates in severe sepsis and septic shock
P056 Neutrophil Extracellular Traps (NETs) production under hypoxic condition
P057 Impact of ultraviolet air sterilizer in intensive care unit room, and clinical outcomes of patients
P058 Focus of infection in severe sepsis - comparison of administrative data and prospective cohorts from Germany
P059 “Zero CLABSI” – can we get there? Obstacles on the 4 year journey and our strategies to overcome them – experience from an Indian ICU
P060 Novel molecular techniques to identify central venous catheter (CVC) associated blood stream infections (BSIs)
P062 Prevention of central line-associated bloodstream infections in intensive care units: An international online survey
P063 30 days antimicrobial efficacy of non-leaching central venous catheters
P064 Efficacy of noble metal alloy-coated catheter in prevention of bacteriuria
P065 Predicting bacteremic urinary tract infection in community setting: A prospective observational study
P066 Eight-year analysis of acinetobacter spp. monobacteremia in surgical and medical intensive care units at university hospital in Lithuania
P067 Group A and group B streptococcal infections in intensive care unit – our experience in a tertiary centre
P068 Improved detection of spontaneous bacterial peritonitis by uritop + tm strip test and inoculation of blood culture bottles with ascitic fluid
P069 Increased risk of cellulitis in patients with congestive heart failure: a population based cohort study
P070 Outcomes of severe cellulitis and necrotizing fasciitis in the critically ill
P071 Botulism outbreak associated with people who inject drugs (PWIDs) in Scotland.
P072 Surveillance of ESBL-producing enterobacteriaceae fecal carriers in the ICU
P073 Prevalence of ESBL and carbapenemase producing uropathogens in a newly opened hospital in south India
P074 Prevalence, risk factors and outcomes of methicillin-resistant staphylococcus aureus nasal colonization in critically ill patients
P075 Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: Is there an association?
P076 Multidrug-resistant organisms in a Dutch ICU
P077 Epidemiology and risk factors of ICU acquired infections caused by multidrug-resistant gram negative bacilli
P078 Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins
P079 Must change the medical practice in ICU?
P080 Mediterranean spotted fever in an infectious diseases intensive care unit
P081 Clinical features and outcomes of patients with Middle East respiratory syndrome requiring admission to a saudi intensive care unit: A retrospective analysis of 31 cases
P082 The ICU response to a hospital outbreak of Middle East respiratory syndrome coronavirus infection
P083 Middle East respiratory syndrome: Surveillance data analysis
P085 Use of Taqman array card molecular diagnostics in severe pneumonia: A case series
P086 ‘BUNS’: An investigation protocol improves the ICU management of pneumonia
P087 Pneumonia in patients following secondary peritonitis: epidemiological features and impact on mortality
P088 The use of the “CURB-65 score” by emergency room clinicians in a large teaching hospital
P089 Incidence of community acquired pneumonia with viral infection in mechanically ventilated patients in the medical intensive care unit
P090 The SAATELLITE Study: Prevention of S aureus Nosocomial Pneumonia (NP) with MEDI4893, a Human Monoclonal Antibody (mAb) Against S aureus
P091 Risk factors and microbiological profile for nosocomial infections in trauma patients
P092 Correlation between percentages of ventilated patients developed vap and use of antimicrobial agents in ICU patients.
P093 A comparison of two ventilator associated pneumonia surveillance techniques
P094 Lung ultrasound before and after fiberbronchoscopy - modifications may improve ventilator-associated pneumonia diagnosis
P095 Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia
P096 Impact of pRBCs transfusion on percentage of ventilated patients developed VAP in ICU patients
P097 The impact of a series of interventions on the rate of ventilator associated pneumonia in a large teaching hospital
P098 The EVADE study: Prevention of Nosocomial Pneumonia (NP) caused by P aeruginosa with MEDI3902, a Novel Bispecific Monoclonal Antibody, against P aeruginosa virulence factors
P099 Short-term inhaled colistin adjunctive therapy for ventilator-associated pneumonia
P100 Effect of aerosolised colistin on weaning from mechanical ventilation
P101 Septic shock is an independent risk factor for colistin-induced severe acute kidney injury: a retrospective cohort study
P102 Nosocomial pneumonia - emphasis on inhaled tobramycin
P103 In vitro evaluation of amikacin inhale and commercial nebulizers in a mechanical ventilator
P104 The effects of nebulized amikacin/fosfomycin and systemic meropenem on severe amikacin-resistant meropenem-susceptible P.aeruginosa pneumonia
P105 Optimization of gentamicin peak concentrations in critically ill patients
P106 Systematic review of cefepime induced neurotoxicity
P107 Unasyn® causes QT prolongation during treatment of intensive care patients
P108 Comparative study between teicoplanin and vancomycin in methicillin-resistant staphylococcus aureus (mrsa) infectious of toxicological intensive care unit (ticu) patients – Tehran, Iran
P109 Phage therapy against antimicrobial resistance, design of the first clinical study phagoburn
P110 Antibiotic dosing errors in critically ill patients with severe sepsis or septic shock
P111 Does empiric antifungal therapy improve survival in septic critically ill patients? (immunocompromised excluded)
P112 Neurocysticercosis-Qatar experience
P113 Early indicators in acute haemorrhagic shock
P114 Filtering of red blood cells reduces the inflammatory response of pulmonary cells in an in vitro model of mechanical ventilation
P115 Microparticles from red blood cell transfusion induce a pro-coagulant and pro-inflammatory endothelial cell response
P116 The contribution of cytokines on thrombosis development during hospitalization in ICU
P117 Prophylactic enoxaparin dosing and adjustment through anti-xa monitoring in an inpatient burn unit
P118 Determination of optimal cut-off values of haemoglobin, platelet count and fibrinogen at 24 hours after injury associated with mortality in trauma patients
P119 Trauma-induced coagulopathy - prothrombin complex concentrate vs fresh frozen plasma
P120 First study to prove the superiority of prothrombin complex concentrates on mortality rate over fresh frozen plasma in patients with acute bleeding
P121 Prothrombin complex concentrate vs fresh frozen plasma in obstetric massive bleeding
P122 Impact of FFP transfusion on VAP in ICU patients
P123 Preoperative platelet function test and the thrombin generation assay are predictive for blood loss after cardiac surgery
P124 Rotational thromboelastometry versus standard coagulation tests before surgical interventions
P125 Correction of impaired clot quality and stability by fibrinogen and activated prothrombin complex concentrate in a model of severe thrombocytopenia
P126 Assessment of point-of-care prothrombin time analyzer as a monitor after cardiopulmonary bypass
P127 Disseminated intravascular coagulation (dic) is underdiagnosed in critically ill patients: do we need d-dimer measurements?
P128 Validity of the age-adjusted d-dimer cutoff in patients with COPD
P129 A scoping review of strategies for prevention and management of bleeding following paediatric cardiopulmonary bypass surgery
P130 Nadir hemoglobulin during cardiopulmonary bypass: impact on postoperative morbidity and mortality
P131 Red blood cell transfusion does not influence the prognostic value of RDW in critically ill patients
P132 Reasons for admission in the paediatric intensive care unit and the need for blood and blood products transfusions
P133 The implementation of a massive haemorrhage protocol (mhp) for the management of major trauma: a ten year, single-centre study
P134 An integrated major haemorrhage protocol for pre-hospital and retrieval medical teams
P135 The impact of transfusion thresholds on mortality and cardiovascular events in patients with cardiovascular disease (non-cardiac surgery): a systematic review and meta-analysis
P136 The relationship between poor pre-operative immune status and outcome from cardiac surgery is specific to the peri-operative antigenic threat
P137 Impact of simple clinical practice guidelines for reducing post-operative atrial fibrillation after cardiac surgery
P138 Dexamethasone administration during cardiopulmonary bypass has no beneficial effects on elective postoperative cardiac surgery patients
P139 Intra-aortic balloon counterpulsation in patients undergoing cardiac surgery (IABCS): preliminary results
P140 Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery-associated acute kidney injury
P141 Acute kidney injury influence on high sensitive troponin measurements after cardiac surgery
P142 Complex evaluation of endothelial dysfunction markers for prognosis of outcomes in patients undergoing cardiac surgery
P143 New-onset atrial fibrillation in intensive care: incidence, management and outcome
P144 One single spot measurement of the sublingual microcirculation during acute pulmonary hypertension in a pig model of shock
P145 Assessment of levosimendan as a therapeutic option to recruit the microcirculation in cardiogenic shock – initial experience in cardiac ICU
P146 Terlipressin vs. norepinephrine in the Potential Multiorgan Donor(PMD)
P147 Echocardiography in the potential heart donor exposed to substitution hormonotherapy
P148 Machine learning can reduce rate of monitor alarms
P149 Peripherally inserted central catheters placed in the ICU
P150 Recordings of abnormal central venous pressure waveform morphology during an episode of pulmonary hypertension in a porcine shock model
P151 Ultrasound guided central venous access technique among French intensivists
P152 Predictive ability of the Pv-aCO2 gap in patients with shock
P153 Comparison of echocardiography and pulmonary artery catheter measurements of hemodynamic parameters in critical ill patients
P154 The volume clamp method for noninvasive cardiac output measurement in postoperative cardiothoracic surgery patients: a comparison with intermittent pulmonary artery thermodilution
P155 Hemodynamic monitoring in patients with septic shock (SS) – CPCCO (continuous pulse contour cardiac output) vs. TEE (transesophageal echocardiography)
P156 Cardiac output measurement with transthoracic echocardiography in critically ill patients: a pragmatic clinical study
P157 Left ventricular outflow tract velocity time integral correlates with stroke volume index in mechanically ventilated patients
P158 Transpulmonary thermodilution (TPTD) derived from femoral vs. jugular central venous catheter: validation of a previously published correction formula and a proprietary correction formula for global end-diastolic volume index (GEDVI)
P159 Venous return driving pressure and resistance in acute blood volume changes
P160 Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients
P161 Analysis of duration of post-operative goal-directed therapy protocol
P162 Hemodynamic optimization – back to square one?
P163 Effectiveness of fluid thoracic content measurement by bioimpedance guiding intravascular volume optimization in patients with septic shock
P164 A systematic review on the role of internal jugular vein ultrasound measurements in assessment of volume status in critical shock patients
P165 Importance of recognizing dehydration in medical Intensive Care Unit
P166 Effect of volume for a fluid challenge in septic patients
P167 Fluid bolus practices in a large Australian intensive care unit
P168 Liberal late fluid management is associated with longer ventilation duration and worst outcome in severe trauma patients: a retrospective cohort of 294 patients
P169 Association of fluids and outcomes in emergency department patients hospitalized with community-acquired pneumonia
P170 Association of positive fluid balance with poor outcome in medicosurgical ICU patients
P171 Impact of fluid balance to organ dysfunction in critically ill patients
P172 Volume bolus in ICU patients: do we need to balance our crystalloids?
P173 The use of 6 % HES solution do not reduce total fluid requirement in the therapy of patients with burn shock
P174 Electron microscopic assessment of acute kidney injury in septic sheep resuscitated with crystalloids or different colloids
P175 Alterations of conjunctival microcirculation in a sheep model of haemorrhagic shock and resuscitation with 0.9 % saline or balanced tetrastarch
P176 A single centre nested pilot study investigating the effect of using 0.9 % saline or Plasma-Lyte 148 ® as crystalloid fluid therapy on gastrointestinal feeding intolerance in mechanically ventilated patients receiving nasogastric enteral nutrition
P177 A single centre nested pilot study investigating the effect on post-operative bleeding of using 0.9 % saline or Plasma-Lyte® 148 as crystalloid fluid therapy in adults in ICU after heart surgery
P178 Extreme hypernatremia and sepsis in a patient with Huntington’s dementia: a conundrum in fluid management
P179 Diagnosis and management of severe hypernatraemia in the critical care setting
P180 Correlation between arterial blood gas and electrolyte disturbances during hospitalization and outcome in critically ill patients
P181 Missing the “I” in MUDPILES – a rare cause of high anion gap metabolic acidosis (HAGMA)
P182 Plasma NGAL and urinary output: potential parameters for early initiation of renal replacement therapy
P183 Renal replacement therapy for critically ill patients: an intermittent continuity
P184 A survey of practices related to renal replacement therapy in critically ill patients in the north of England.
P185 High initiation creatinine associated with lower 28-day mortality in critically ill patients necessitating continuous renal replacement therapy
P186 The impact of Karnofsky performance scale on outcomes in acute kidney injury patients receiving renal replacement therapy on the intensive care unit
P187 Severe hypophosphatemia during citrate-anticoagulated CRRT
P188 Citrate regional anticoagulation for post dilution continuous renal replacement therapy
P189 Citrate 18 mmol/l improves anticoagulation during RRT with adsorbing filters
P190 Calcium gluconate instead of calcium chloride in citrate-anticoagulated CVVHD
P191 Enhanced clearance of interleukin-6 with continuous veno-venous haemodialysis (CVVHD) using Ultraflux EMiC2 vs. Ultraflux AV1000S
P192 Removal of bilirubin with a new adsorbent system: in vitro kinetics
P193 Case series of patients with severe sepsis and septic shock treated with a new extracorporeal sorbent
P194 In vitro adsorption of a broad spectrum of inflammatory mediators with CytoSorb® hemoadsorbent polymer beads
P195 Observations in early vs. late use of cytosorb therapy in critically ill patients
P196 Oxiris membrane decreases endotoxin during rrt in septic patients with basal EAA>0,6
P197 An observational prospective study on the onset of augmented renal clearance: the first report
P198 An ultrasound- guided algorithm for the management of oliguria in severe sepsis
P199 Ultrasound in acute kidney injury (aki). First findings of farius, an education-programme in structural ultrasonography
P200 Effectiveness of renal angina index score predicting acute kidney injury on critically ill patients
P201 Time length below blood pressure thresholds and progression of acute kidney injury in critically ill patients with or without sepsis: a retrospective, exploratory cohort study
P202 Anaemia does not affect renal recovery in acute kidney injury
P203 Estimated glomerular filtration rate based on serum creatinine: actual practice in Dutch ICU’s
P204 Comparison of estimated glomerular filtration rate calculated by mdrd, ckd-epi-serum-creatinine and ckd-epi-cystatin-c in adult critically ill patients
P205 Early diagnosis of septic acute kidney injury in medical critical care patients with a urine cell cycle arrest marker: insulin like growth factor binding protein-7 (IGFBP-7)
P206 Urinary neutrophil gelatinase-associated lipocalin as early biomarker of severe acute kidney injury in intensive care
P207 Shrunken pore syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting
P208 The biomarker nephrocheck™ can discriminate the septic shock patients with an akin 1 or 2 acute renal failure who will not progress toward the akin 3 level
P209 A worldwide multicentre evaluation of acute kidney injury in septic and non-septic critically ill patients: the intensive care over nations (ICON) audit
P210 Does enhanced recovery after surgery reduce the incidence of acute kidney injury in those undergoing major gynae-oncological surgery?
P211 Identification of risk factors for the development of acute kidney injury after lower limb arthroplasty
P212 Incidences and associations of acute kidney injury after major trauma
P213 Acute kidney injury of major trauma patients
P214 Trajectory of serum creatinine after major surgery and the diagnosis of acute kidney injury
P215 Epidemiology of acute kidney injury after cardiac surgery. A single center retrospective study
P216 Post-operative acute kidney injury after major non-cardiac surgery and its association with death in the following year
P217 Factors affecting acute renal failure in intensive care unit and effect of these factors on mortality
P218 Results of the live kidney transplantations according to national data of turkish organ and tissue information system
P219 Anaesthesia procedure and intensive therapy in patients with neck phlegmon
P220 Nasal high flow oygen for acute respiratory failure: a systematic review
P221 Setting optimal flow rate during high flow nasal cannula support: preliminary results
P222 Dose to dose consistency across two different gas flow rates using cystic fibrosis and normal adult breathing profiles during nasal high flow oxygen therapy
P223 Final results of an evaluation of airway medix closed suction system compared to a standard closed suction system
P224 Different cuff materials and different leak tests - one size does not fit all
P225 Observational study on the value of the cuff-leak test and the onset of upper airway obstruction after extubation
P226 A device for emergency transtracheal lung ventilation
P227 Long-term outcome and health-related quality of life in patients discharged from the intensive care unit with a tracheostomy and with or without prolonged mechanical ventilation
P228 Ultrasound-guided percutaneous dilational tracheostomy versus bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients (trachus): a randomized clinical trial
P229 Is it safe to discharge patients with tracheostomy from the ICU to the ward?
P230 The application of tracheostomy in children in ICU
P231 The impact of passive humidifiers on aerosol drug delivery during mechanical ventilation
P232 Evaluation of vibrating mesh and jet nebuliser performance at two different attachment setups in line with a humidifier nebuliser system
